Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN112174837B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112174837B reveals a novel Boc-protected aziridine route for high-purity chiral amine intermediates, offering significant cost reduction and supply chain reliability for asthma drug manufacturing.